henry meds glp-1 Review: Telehealth Provider Analysis – PlexusDx Henry Meds TV Spot, 'GLP-1:

doi: 10.1007/s40262-015-0338-3

In April 2025, the Trump Administration announced that Medicare and Medicaid would not cover anti-obesity drugs in 2026, reversing a prior expansion effort

Administered once weekly, GLP-1 therapy injections have been shown to result in weight loss exceeding 50 pounds in as little as six months an attractive option for individuals looking to achieve substantial weight reduction efficiently

As a physician led destination for medical aesthetics and wellness, the team shared insight into the benefits they are seeing firsthand in patients navigating their wellness journeys

Regional Snapshot 16.3